Mahmoud A A Ibrahim

InstitutionMinia University
AddressMinia
Egypt
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 14 Covid-19 publications, with a maximum of 2 publications in July 2020 and May 2021 and July 2021
    All Publications
    Bar chart showing 28 publications over 7 distinct years, with a maximum of 8 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Yosri N, Abd El-Wahed AA, Ghonaim R, Khattab OM, Sabry A, Ibrahim MAA, Moustafa MF, Guo Z, Zou X, Algethami AFM, Masry SHD, AlAjmi MF, Afifi HS, Khalifa SAM, El-Seedi HR. Anti-Viral and Immunomodulatory Properties of Propolis: Chemical Diversity, Pharmacological Properties, Preclinical and Clinical Applications, and In Silico Potential against SARS-CoV-2. Foods. 2021 Jul 31; 10(8). PMID: 34441553.
      Citations: 2     
    2. Ibrahim MAA, Abdelrahman AHM, Atia MAM, Mohamed TA, Moustafa MF, Hakami AR, Khalifa SAM, Alhumaydhi FA, Alrumaihi F, Abidi SH, Allemailem KS, Efferth T, Soliman ME, Paré PW, El-Seedi HR, Hegazy MF. Blue Biotechnology: Computational Screening of Sarcophyton Cembranoid Diterpenes for SARS-CoV-2 Main Protease Inhibition. Mar Drugs. 2021 Jul 13; 19(7). PMID: 34356816.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    3. Akbay B, Abidi SH, Ibrahim MAA, Mukhatayev Z, Ali S. Multi-Subunit SARS-CoV-2 Vaccine Design Using Evolutionarily Conserved T- and B- Cell Epitopes. Vaccines (Basel). 2021 Jun 26; 9(7). PMID: 34206865.
      Citations:    
    4. Elsbaey M, Ibrahim MAA, Bar FA, Elgazar AA. Chemical constituents from coconut waste and their in silico evaluation as potential antiviral agents against SARS-CoV-2. S Afr J Bot. 2021 Sep; 141:278-289. PMID: 34092840.
      Citations: 1     
    5. Abidi SH, Almansour NM, Amerzhanov D, Allemailem KS, Rafaqat W, Ibrahim MAA, la Fleur P, Lukac M, Ali S. Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase. Sci Rep. 2021 05 13; 11(1):10290. PMID: 33986405.
      Citations:    Fields:    Translation:HumansCells
    6. Ibrahim MAA, Abdelrahman AHM, Mohamed TA, Atia MAM, Al-Hammady MAM, Abdeljawaad KAA, Elkady EM, Moustafa MF, Alrumaihi F, Allemailem KS, El-Seedi HR, Paré PW, Efferth T, Hegazy MF. In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (Mpro) Inhibitors. Molecules. 2021 Apr 05; 26(7). PMID: 33916461.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    7. Ibrahim MAA, Mohamed EAR, Abdelrahman AHM, Allemailem KS, Moustafa MF, Shawky AM, Mahzari A, Hakami AR, Abdeljawaad KAA, Atia MAM. Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study. J Mol Graph Model. 2021 06; 105:107904. PMID: 33798836.
      Citations: 9     Fields:    Translation:Humans
    8. Ibrahim MAA, Abdelrahman AHM, Allemailem KS, Almatroudi A, Moustafa MF, Hegazy MF. In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors. Protein J. 2021 06; 40(3):296-309. PMID: 33387249.
      Citations: 10     Fields:    Translation:Humans
    9. Alshammari MB, Ramadan M, Aly AA, El-Sheref EM, Bakht MA, Ibrahim MAA, Shawky AM. Synthesis of potentially new schiff bases of N-substituted-2-quinolonylacetohydrazides as anti-COVID-19 agents. J Mol Struct. 2021 Apr 15; 1230:129649. PMID: 33223566.
      Citations: 1     
    10. Ibrahim MAA, Abdelrahman AHM, Hussien TA, Badr EAA, Mohamed TA, El-Seedi HR, Pare PW, Efferth T, Hegazy MF. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors. Comput Biol Med. 2020 11; 126:104046. PMID: 33065388.
      Citations: 24     Fields:    Translation:HumansCellsPHPublic Health
    11. Aly AA, Hassan AA, Mohamed AH, Osman EM, Bräse S, Nieger M, Ibrahim MAA, Mostafa SM. Synthesis of 3,3'-methylenebis(4-hydroxyquinolin-2(1H)-ones) of prospective anti-COVID-19 drugs. Mol Divers. 2021 Feb; 25(1):461-471. PMID: 32926254.
      Citations: 1     Fields:    Translation:HumansCells
    12. Ibrahim MAA, Abdelrahman AHM, Hegazy MF. In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors. J Biomol Struct Dyn. 2021 09; 39(15):5756-5767. PMID: 32684114.
      Citations: 13     Fields:    Translation:HumansCells
    13. Ibrahim MAA, Abdeljawaad KAA, Abdelrahman AHM, Hegazy MF. Natural-like products as potential SARS-CoV-2 Mpro inhibitors: in-silico drug discovery. J Biomol Struct Dyn. 2021 09; 39(15):5722-5734. PMID: 32643529.
      Citations: 18     Fields:    Translation:HumansCells
    14. Kandeel M, Abdelrahman AHM, Oh-Hashi K, Ibrahim A, Venugopala KN, Morsy MA, Ibrahim MAA. Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease. J Biomol Struct Dyn. 2021 09; 39(14):5129-5136. PMID: 32597315.
      Citations: 19     Fields:    Translation:Humans
    Ibrahim's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (92)
    Explore
    _
    Co-Authors (65)
    Explore
    _
    Similar People (60)
    Explore
    _